Information for "ANMC ADULT Procalcitonin (PCT) Utilization Guideline/Clinical Pathway"
From Guide to YKHC Medical Practices
| Display title | ANMC ADULT Procalcitonin (PCT) Utilization Guideline/Clinical Pathway |
| Default sort key | ANMC ADULT Procalcitonin (PCT) Utilization Guideline/Clinical Pathway |
| Page length (in bytes) | 14,316 |
| Page ID | 795 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
View the protection log for this page.
| Page creator | Mfaubion (talk | contribs) |
| Date of page creation | 20:27, 20 March 2019 |
| Latest editor | JenniferH (talk | contribs) |
| Date of latest edit | 23:51, 2 February 2021 |
| Total number of edits | 5 |
| Total number of distinct authors | 2 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
